Article
Analyses of flap thickness showed favorable predictability.
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Nanoscope Therapeutics initiates rolling submission of BLA to FDA for MCO-010
3 Things You Should Know About Interventional Glaucoma Comanagement
Krystal Biotech doses first patient in EMERALD-1 phase 1/2 trial for neurotrophic keratitis
Patient-Centered Treatment Strategies in the Management of nAMD and DME
Navigate successful cataract surgery with refractive technology
LIGHTHOUSE study of ATSN-201 expanded to continuous phase 1/2/3 trial following FDA feedback